Early growth response gene-1 promotes airway allograft rejection

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 293, Issue 1, 2007, Pages

  Harada, Hiroaki ^a   Lama, Vibha N ^a   Badri, Linda N ^a   Ohtsuka, Takashi ^a   Petrovic Djergovic, Danica ^a   Liao, Hui ^a   Yoshikawa, Yasushi ^a   Iwanaga, Koichiro ^a   Lau, Chris L ^a   Pinsky, David J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Inflammation; Lymphocytic bronchiolitis; Obliterative bronchiolitis; Transplantation

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; EARLY GROWTH RESPONSE GENE 1; GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; STATISTICAL SIGNIFICANCE; SURVIVAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; CYTOKINES; EARLY GROWTH RESPONSE PROTEIN 1; GENE EXPRESSION REGULATION; GRAFT REJECTION; LEUKOCYTES, MONONUCLEAR; LUNG TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34447540160     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00285.2006     Document Type: Article

References (38)

1. Alho HS, Maasilta PK, Harjula AL, Hammainen P, Salminen J, Salminen US. Tumor necrosis factor-alpha in a porcine bronchial model of obliterative bronchiolitis. Transplantation 76: 516-523, 2003.
2. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 340: 1081-1091, 1999.
3. Aris RM, Walsh S, Chalermskulrat W, Hathwar V, Neuringer IP. Growth factor upregulation during obliterative bronchiolitis in the mouse model. Am J Respir Crit Care Med 166: 417-422, 2002.
4. Belperio JA, Keane MP, Burdick MD, Lynch JP 3rd, Xue YY, Li K, Ross DJ, Strieter RM. Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome. J Immunol 169: 1037-1049, 2002.
5. Boehler A, Chamberlain D, Kesten S, Slutsky AS, Liu M, Keshavjee S. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation 64: 311-317, 1997.
6. Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: a review. Chest 114: 1411-1426, 1998.
7. Chamberlain D, Maurer J, Chaparro C, Idolor L. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 13: 963-971, 1994.
8. Cibelli G, Policastro V, Rossler OG, Thiel G. Nitric oxide-induced programmed cell death in human neuroblastoma cells is accompanied by the synthesis of Egr-1, a zinc finger transcription factor. J Neurosci Res 67: 450-460, 2002.
9. DeMeo DL, Ginns LC. Lung transplantation at the turn of the century. Annu Rev Med 52: 185-201, 2001.
10. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 21: 297-310, 2002.
11. Farivar AS, Mackinnon-Patterson B, Woolley S, Namkung J, Shimamoto A, Verrier ED, Mulligan MS. FR167653 reduces obliterative airway disease in rats. J Heart Lung Transplant 23: 985-992, 2004.
12. Fernandez FG, Jaramillo A, Chen C, Liu DZ, Tung T, Patterson GA, Mohanakumar T. Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease. Am J Transplant 4: 319-325, 2004.
13. Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 142: 1945-1951, 1993.
14. + T cells. Transplantation 74: 646-651, 2002.
15. + CTLs recognizing a single minor histocompatibility antigen. J Immunol 174: 1871-1878, 2005.
16. Hruban RH, Beschorner WE, Baumgartner WA, Achuff SC, Traill TA, Marsh BR, Gupta PK, Hutchins GM, Reitz BA. Diagnosis of lung allograft rejection by bronchial intraepithelial Leu-7 positive T lymphocytes. J Thorac Cardiovasc Surg 96: 939-946, 1988.
17. Kelly K, Hertz MI. Obliterative bronchiolitis. Clin Chest Med 18: 319-338, 1997.
18. King MB, Pedtke AC, Levrey-Hadden HL, Hertz MI. Obliterative airway disease progresses in heterotopic airway allografts without persistent alloimmune stimulus. Transplantation 74: 557-562, 2002.
19. Lama VN, Harada H, Badri LN, Flint A, Hogaboam CM, McKenzie A, Martinez FJ, Toews GB, Moore BB, Pinsky DJ. Obligatory role for interleukin-13 in obstructive lesion development in airway allografts. Am J Pathol 169: 47-60, 2006.
20. Lappi-Blanco E, Soini Y, Kinnula V, Paakko P. VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia. J Pathol 196: 220-227, 2002.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta CT) method. Methods 25: 402-408, 2001.
22. McCaffrey TA, Fu C, Du B, Eksinar S, Kent KC, Bush H Jr, Kreiger K, Rosengart T, Cybulsky MI, Silverman ES, Collins T. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest 105: 653-662, 2000.
23. Minamoto K, Harada H, Lama VN, Fedarau MA, Pinsky DJ. Reciprocal regulation of airway rejection by the inducible gas-forming enzymes heme oxygenase and nitric oxide synthase. J Exp Med 202: 283-294, 2005.
24. Minamoto K, Pinsky DJ. Recipient iNOS but not eNOS deficiency reduces luminal narrowing in tracheal allografts. J Exp Med 196: 1321-1333, 2002.
25. Mishra S, Fujita T, Lama VN, Nam D, Liao H, Okada M, Minamoto K, Yoshikawa Y, Harada H, Pinsky DJ. Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc Natl Acad Sci USA 103: 5191-5196, 2006.
26. Molor-Erdene P, Okajima K, Isobe H, Uchiba M, Harada N, Okabe H. Urinary trypsin inhibitor reduces LPS-induced hypotension by suppressing tumor necrosis factor-α production through inhibition of Egr-1 expression. Am J Physiol Heart Circ Physiol 288: H1265-H1271, 2005.
27. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, Pinsky DJ, Watkins SC, Pilewski JM, Sciurba FC, Peters DG, Hogg JC, Choi AM. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 101: 14895-14900, 2004.
28. Okada M, Wang CY, Hwang DW, Sakaguchi T, Olson KE, Yoshikawa Y, Minamoto K, Mazer SP, Yan SF, Pinsky DJ. Transcriptional control of cardiac allograft vasculopathy by early growth response gene-1 (Egr-1). Circ Res 91: 135-142, 2002.
29. Okada M, Yan SF, Pinsky DJ. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J 16: 1861-1868, 2002.
30. Ressler B, Lee RT, Randell SH, Drazen JM, Kamm RD. Molecular responses of rat tracheal epithelial cells to transmembrane pressure. Am J Physiol Lung Cell Mol Physiol 278: L1264-L1272, 2000.
31. Reynaud-Gaubert M, Marin V, Thirion X, Farnarier C, Thomas P, Badier M, Bongrand P, Giudicelli R, Fuentes P. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration. J Heart Lung Transplant 21: 721-730, 2002.
32. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 152: 5135-5141, 1994.
33. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 21: 271-281, 2002.
34. Sundaresan S, Mohanakumar T, Smith MA, Trulock EP, Lynch J, Phelan D, Cooper JD, Patterson GA. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 65: 648-653, 1998.
35. Trulock EP. Lung transplantation. Am J Respir Crit Care Med 155: 789-818, 1997.
36. Yan SF, Fujita T, Lu J, Okada K, Shan Zou Y, Mackman N, Pinsky DJ, Stern DM. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 6: 1355-1361, 2000.
37. Yousem SA. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol 17: 491-496, 1993.
38. Yousem SA, Berry GJ, Cagle PT, Chamberlain D, Husain AN, Hruban RH, Marchevsky A, Ohori NP, Ritter J, Stewart S, Tazelaar HD. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 15: 1-15, 1996.